Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the safety and efficacy of Levomilnacipran ER for fatigue associated with Major Depressive Disorder in adults; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Levomilnacipran ER (levomilnacipran hydrochloride)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-08-06